Factors at presentation which influenced the course of the disease and
response to treatment were assessed in 125 de novo patients with Park
inson's disease. Ninety-eight patients were available for re-assessmen
t at 5 years. Older patients presented earlier after the onset of symp
toms, deteriorated more rapidly, and were significantly more likely to
develop dementia and impairment of balance. Increasing age and symmet
rical disease predicted the new appearance of imbalance. Age of onset
did not predict dyskinesia or end of dose failure, A low tremor score
at baseline and female gender were predictive of the early appearance
of dyskinesia. Patients who experienced end of dose failure were takin
g a significantly higher dose of levodopa. Once dose and duration of t
reatment were corrected for, no baseline features were predictive of e
nd of dose failure. The dose of levodopa at 5 years was positively cor
related to baseline disease severity as measured by the Columbia score
. We conclude that the age of onset of symptoms of Parkinson's disease
is a major determinant of the course of the disease and response to t
reatment.